GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » SciBase Holding AB (OSTO:SCIB) » Definitions » Gross Profit

SciBase Holding AB (OSTO:SCIB) Gross Profit : kr21.08 Mil (TTM As of Dec. 2024)


View and export this data going back to 2015. Start your Free Trial

What is SciBase Holding AB Gross Profit?

SciBase Holding AB's gross profit for the three months ended in Dec. 2024 was kr5.89 Mil. SciBase Holding AB's gross profit for the trailing twelve months (TTM) ended in Dec. 2024 was kr21.08 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. SciBase Holding AB's gross profit for the three months ended in Dec. 2024 was kr5.89 Mil. SciBase Holding AB's Revenue for the three months ended in Dec. 2024 was kr8.60 Mil. Therefore, SciBase Holding AB's Gross Margin % for the quarter that ended in Dec. 2024 was 68.49%.

SciBase Holding AB had a gross margin of 68.49% for the quarter that ended in Dec. 2024 => Durable competitive advantage

During the past 12 years, the highest Gross Margin % of SciBase Holding AB was 70.96%. The lowest was 2.48%. And the median was 53.54%.


SciBase Holding AB Gross Profit Historical Data

The historical data trend for SciBase Holding AB's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SciBase Holding AB Gross Profit Chart

SciBase Holding AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.00 6.58 11.24 16.04 21.08

SciBase Holding AB Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.24 4.23 4.59 6.36 5.89

Competitive Comparison of SciBase Holding AB's Gross Profit

For the Medical Devices subindustry, SciBase Holding AB's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SciBase Holding AB's Gross Profit Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, SciBase Holding AB's Gross Profit distribution charts can be found below:

* The bar in red indicates where SciBase Holding AB's Gross Profit falls into.


;
;

SciBase Holding AB Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

SciBase Holding AB's Gross Profit for the fiscal year that ended in Dec. 2024 is calculated as

Gross Profit (A: Dec. 2024 )=Revenue - Cost of Goods Sold
=29.705 - 8.628
=21.08

SciBase Holding AB's Gross Profit for the quarter that ended in Dec. 2024 is calculated as

Gross Profit (Q: Dec. 2024 )=Revenue - Cost of Goods Sold
=8.598 - 2.709
=5.89

Gross Profit for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr21.08 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

SciBase Holding AB's Gross Margin % for the quarter that ended in Dec. 2024 is calculated as

Gross Margin % (Q: Dec. 2024 )=Gross Profit (Q: Dec. 2024 ) / Revenue (Q: Dec. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=5.89 / 8.598
=68.49 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


SciBase Holding AB  (OSTO:SCIB) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

SciBase Holding AB had a gross margin of 68.49% for the quarter that ended in Dec. 2024 => Durable competitive advantage


SciBase Holding AB Gross Profit Related Terms

Thank you for viewing the detailed overview of SciBase Holding AB's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


SciBase Holding AB Business Description

Traded in Other Exchanges
N/A
Address
Landsvagen 39, Sundbyberg, Stockholm, SWE, 172 63
SciBase Holding AB is a medical technology company that develops devices for the evaluation of skin disorders such as skin cancer and atopic dermatitis. SciBase's products include Nevisense and Nevisense Go and to date, the platform addresses the areas of melanoma detection, non-melanoma skin cancer detection, and skin barrier assessment. It is the only FDA-approved device for the detection of melanoma and the only MDR-approved technology for skin cancer detection in Europe. The company operates in two segments which includes skin cancer and skin barrier assessment. Majority of the revenue is generated from skin cancer segment. Its geographical segments are Europe/Rest of the World, the United States/North America, and Asia/Oceania.

SciBase Holding AB Headlines

No Headlines